中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
A review of advances in imaging methodology in fluorescence molecular tomography 期刊论文
PHYSICS IN MEDICINE AND BIOLOGY, 2022, 卷号: 67, 期号: 10, 页码: 25
作者:  Zhang, Peng;  Ma, Chenbin;  Song, Fan;  Fan, Guangda;  Sun, Yangyang;  Feng, Youdan;  Ma, Xibo;  Liu, Fei;  Zhang, Guanglei
收藏  |  浏览/下载：213/0  |  提交时间：2022/06/10
fluorescence tomography  forward and inverse problem  ill-posedness  reconstruction method  deep learning  
A Novel Adaptive Parameter Search Elastic Net Method for Fluorescent Molecular Tomography 期刊论文
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2021, 卷号: 40, 期号: 5, 页码: 1484-1498
作者:  Wang, Hanfan;  Bian, Chang;  Kong, Lingxin;  An, Yu;  Du, Yang;  Tian, Jie
Adobe PDF(8176Kb)  |  收藏  |  浏览/下载：432/69  |  提交时间：2021/06/15
Image reconstruction  Fluorescence  Probes  Mathematical model  Photonics  Molecular imaging  Biological tissues  Fluorescence molecular tomography  adaptive parameter search  elastic net  
Non-Negative Iterative Convex Refinement Approach for Accurate and Robust Reconstruction in Cerenkov Luminescence Tomography 期刊论文
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2020, 卷号: 39, 期号: 10, 页码: 3207-3217
作者:  Cai, Meishan;  Zhang, Zeyu;  Shi, Xiaojing;  Yang, Junying;  Hu, Zhenhua;  Tian, Jie
Adobe PDF(2176Kb)  |  收藏  |  浏览/下载：345/71  |  提交时间：2021/01/07
Image reconstruction  Imaging  Mathematical model  Shape  Slabs  Iterative methods  Luminescence  Cerenkov luminescence tomography  sparse reconstruction  inverse problem  tumor  
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images 期刊论文
Theranostics, 2020, 卷号: 0, 期号: 0, 页码: 0
作者:  Tian, Panwen;  He, Bingxi;  Dong, Di;  Mu, Wei;  Liu, Kunqin;  Liu, Li;  Zeng, Hao;  Liu, Yujie;  Jiang, Lili;  Zhou, Ping;  Huang, Zhipei;  Li, Weimin;  Tian, Jie
浏览  |  Adobe PDF(1539Kb)  |  收藏  |  浏览/下载：309/122  |  提交时间：2020/10/25
PD-L1 expression  deep learning  computed tomography  immunotherapy  non-small cell lung cancer.